Stocks · Health care · Pharmaceutical Preparations

Seres Therapeutics, Inc.

MCRB Clue Score46
United States Fiscal year ends December CIK 0001609809 Results filed 4 Nov 2026

What the insiders did Mostly scheduled

Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$54.88K
$5.35K on a plan · $49.09K straight out of an exercise
Sold at will
$444.27
1 of 16 sales
Net
−$54.88K
−$444.27 against sales at will